The stepwise protonation of ethylenediamine-containing peptides at low pH in endosomes is hypothesized to disrupt the endosomal membrane and enhance cytosolic delivery. Incorporation of a novel glutamic acid analog bearing an ethylenediamine moiety into TAT peptides markedly enhanced cytosolic delivery without cytotoxicity.